1. Louis E, Ramos‑Goñi JM, Cuervo J, Kopylov U ,
Barreiro‑de Acosta M, McCartney S, et al. A qualitative
research for defining meaningful attributes for the treatment of
inflammatory bowel disease from the patient perspective. Patient
2020;13:317‑25.
2. Casellas F, Guise CH, Robles V, Navarro E, Borruel N. Patient
preferences for infammatory bowel disease treatment objectives.
Dig Liver Dis 2017;49:152‑6.
3. Kamp KJ, Brittain K. Factors that infuence treatment and
nontreatment decision making among individuals with
infammatory bowel disease: An integrative review. Patient
2018;11:271‑84.
4. M’Koma AE. Inflammatory bowel disease: An expanding global
health problem. Clin Med Insights Gastroenterol 2013;6:33‑47.
5. Mohsenizadeh SM, Manzari ZS, Vosoghinia H, Ebrahimipour H.
Family caregivers’ burden in inflammatory bowel diseases: An
integrative review. J Educ Health Promot 2020;9:289.
6. Mikocka‑Walus AA, Andrews JM, Bernstein CN, Graff LA,
WalkerJR, Spinelli A, et al. Integrated models of care in managing
inflammatory bowel disease: A discussion. Inflamm Bowel Dis
2012;18:1582‑7.
7. Grady PA, Gough LL. Self‑management: A comprehensive
approach to management of chronic conditions. Am J Public
Health 2014;104:e25‑31.
8. Jalilian F, Motlagh FZ, Solhi M, Gharibnavaz H. Effectiveness of
self‑management promotion educational program among diabetic
patients based on health belief model. J Educ Health Promot
2014;3:14.
9. Miller WR, Lasiter S, Bartlett Ellis R, Buelow JM. Chronic disease
self‑management: A hybrid concept analysis. Nurs Outlook
2015;63:154‑61.
10. Tran L, Mulligan K. A systematic review of self‑management
interventions for children and adolescents with inflammatory
bowel disease. Inflamm Bowel Dis 2019;25:685‑98.
11. Plevinsky JM, Greenley RN, Fishman LN. Self‑management in
patients with inflammatory bowel disease: Strategies, outcomes,
and integration into clinical care. Clin Exp Gastroenterol
2016;9:259‑67.
12. Hsieh HF, Shannon SE. Three approaches to qualitative content
analysis. Qual Health Res 2005;15:1277‑88.
13. Lincoln YS. Emerging criteria for quality in qualitative and
interpretive research. Qual Inq 1995;1:275‑89.
14. Zare F, Ghafari M, Ramezankhani A, Kamran BL, Kavoosi A.
Identifying dimensions of empowerment in patients with
inflammatory bowel disease: A qualitative study. Health Educ
Res 2020;35:637‑47.
15. Sykes DN, Fletcher PC, Schneider MA. Balancing my disease:
Women’s perspectives of living with inflammatory bowel disease.
J Clin Nurs 2015;24:2133‑42.
16. Pittet V, Vaucher C, Froehlich F, Burnand B, Michetti P,
Maillard MH, et al. Patient self‑reported concerns in inflammatory
bowel diseases: A gender‑specific subjective quality‑of‑life
indicator. PLoS One 2017;12:e0171864.
17. Trivedi I, Darguzas E, Balbale SN, Bedell A, Reddy S,
Rosh JR, et al. Patient understanding of “Flare” and
“Remission” of inflammatory bowel disease. Gastroenterol Nurs
2019;42:375‑85.
18. Jelsness‑Jørgensen LP, Moum B, Bernklev T. Worries and
concerns among inflammatory bowel disease patients
followed prospectively over one year. Gastroenterol Res Pract
2011;2011:492034.
19. KeetonRL, Mikocka‑WalusA, Andrews JM. Concerns and worries
in people living with inflammatory bowel disease (IBD): A mixed
methods study. J Psychosom Res 2015;78:573‑8.
20. Larsson K, Lööf L, Nordin K. Stress, coping and support needs of
patients with ulcerative colitis or Crohn’s disease: A qualitative
descriptive study. J Clin Nurs 2017;26:648‑57.
21. CooperJM, CollierJ, James V, Hawkey CJ. Beliefs about personal
control and self‑management in 30‑40 year olds living with
inflammatory bowel disease: A qualitative study. Int J Nurs Stud
2010;47:1500‑9.
22. Bishop J, Lemberg DA, Day A. Managing inflammatory bowel
disease in adolescent patients. Adolesc Health Med Ther
2014;5:1‑3.